首页> 美国卫生研究院文献>Springer Open Choice >Peptide microarrays for the profiling of cytotoxic T-lymphocyte activity using minimum numbers of cells
【2h】

Peptide microarrays for the profiling of cytotoxic T-lymphocyte activity using minimum numbers of cells

机译:使用最少数量的细胞来分析细胞毒性T淋巴细胞活性的肽微阵列

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The identification of epitopes that elicit cytotoxic T-lymphocyte activity is a prerequisite for the development of cancer-specific immunotherapies. However, especially the parallel characterization of several epitopes is limited by the availability of T cells. Microarrays have enabled an unprecedented miniaturization and parallelization in biological assays. Here, we developed peptide microarrays for the detection of CTL activity. MHC class I-binding peptide epitopes were pipetted onto polymer-coated glass slides. Target cells, loaded with the cell-impermeant dye calcein, were incubated on these arrays, followed by incubation with antigen-expanded CTLs. Cytotoxic activity was detected by release of calcein and detachment of target cells. With only 200,000 cells per microarray, CTLs could be detected at a frequency of 0.5% corresponding to 1,000 antigen-specific T cells. Target cells and CTLs only settled on peptide spots enabling a clear separation of individual epitopes. Even though no physical boundaries were present between the individual spots, peptide loading only occurred locally and cytolytic activity was confined to the spots carrying the specific epitope. The peptide microarrays provide a robust platform that implements the whole process from antigen presentation to the detection of CTL activity in a miniaturized format. The method surpasses all established methods in the minimum numbers of cells required. With antigen uptake occurring on the microarray, further applications are foreseen in the testing of antigen precursors that require uptake and processing prior to presentation.
机译:鉴定引起细胞毒性T淋巴细胞活性的表位是开发癌症特异性免疫疗法的先决条件。但是,特别是几个表位的平行表征受到T细胞可用性的限制。微阵列已经实现了生物学测定中前所未有的小型化和并行化。在这里,我们开发了用于检测CTL活性的肽微阵列。将MHC I类结合肽表位吸移到涂有聚合物的载玻片上。在这些阵列上孵育装有细胞不渗透染料钙黄绿素的靶细胞,然后与抗原扩增的CTL孵育。通过钙黄绿素的释放和靶细胞的分离来检测细胞毒活性。每个微阵列只有200,000个细胞,CTL的检测频率为0.5%,相当于1,000个抗原特异性T细胞。靶细胞和CTL仅固定在肽点上,从而能够清楚地分离各个表位。即使在各个斑点之间不存在物理边界,肽的装载也仅局部发生,并且溶细胞活性被限制在携带特定表位的斑点上。肽微阵列提供了一个强大的平台,该平台以小型化形式实现了从抗原呈递到CTL活性检测的整个过程。该方法在所需的最小单元数方面超过了所有已建立的方法。随着微阵列上发生抗原吸收,预计在抗原呈递前需要吸收和加工的抗原前体的测试中会进一步应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号